RxDoctor Payments Data

Michael Chang, MD

Dermatology · Albuquerque, NMNPI 1326337122

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $874 of the $1,036 with a category attached, or 84.3%. 13 manufacturers reported payments, led by Johnson & Johnson at 27.3% of the total. 2025 is the largest year on record at $477, 5.3 times the $90 reported in 2019. That places this record below the midpoint for dermatology clinicians in NM, where the typical reported total is $1,036.

$1,036in general payments, 2019–2025

Across 33 payments — averaging $31.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$282
  • UCB, Inc.$216
  • Novartis$180
  • Janssen Scientific Affairs, LLC$114
  • AbbVie$60
  • Amgen$29
  • plus $154 from 7 others

What the payments were for

  • Travel & lodging$636%
  • Food & beverage$87484%
  • Education$10010%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,036 in reported general payments places this provider in the 50th percentile of 52 dermatology providers in New Mexico.

See all dermatology providers in New Mexico

Medicare billing

Part B allowed, 2024
$658,152
Medicare patients
909
Services billed
6,031

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab14$90,714
Fluocinonide77$3,810
Fluorouracil26$2,704
Cephalexin117$1,909
Ketoconazole132$1,737
Doxycycline Monohydrate20$1,515
Metronidazole38$1,377
Triamcinolone Acetonide98$1,074
Clobetasol Propionate36$996
Clindamycin Phosphate25$557
Ciclopirox23$474
Hydrocortisone33$281
Doxycycline Hyclate15$246
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$99
Mupirocin12$76

Paid to pharmacies, not to this prescriber.

Other dermatology in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →